Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Thymosin β4 promotes hair growth by activating stem cells in hair follicles.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Three compounds from Dadap leaves may help treat hair loss.

Different Hairless isoforms affect Vitamin D receptor activity in hair regulation, with one repressing and the other stimulating it.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

A genetic mutation in the hHa1 gene creates a smaller, but still functional, hair protein without causing hair problems.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Smad4 is important for healthy hair follicles because it helps produce a protein needed for hair to stick together and grow.

Quadruple-coated probiotics significantly improve IBS symptoms.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Trichohyalin helps in hair and skin cell structure and function by binding calcium and linking proteins.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Overactive signaling in hair follicles can lead to skin cancer.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

HAT-L4 is crucial for preventing body fluid loss by maintaining skin barrier integrity.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

hHb1, hHb3, and hHb6 mRNAs start expressing at the same time in hair follicles.